Evidence for increased lipid peroxidation in multiple sclerosis
Pentane and ethane are degradation products of unsaturated fatty acids which are released during lipid peroxidation. In order to assess whether multiple sclerosis is associated with lipid peroxidation, we measured pentane and ethane excretion by 16 patients with multiple sclerosis and compared them to healthy control subjects. Patients with acute exacerbation of multiple sclerosis had significantly higher concentrations of pentane (10.5±4.2 nmol/l)(p<0.01) compared to either patients in remission (4.5±1.7 nmol/l) or control subjects (4.9±1.1 nmol/l). The concentrations of ethane were not significantly different among these groups. Of the patients with acute exacerbation who later achieved remission, the pentane excretion also returned to normal (5.6±0.9 nmol/l). One patient who failed to reachieve clinical remission continued to excrete large amounts of pentane. We conclude that oxygen free radical activity is enhanced during exacerbation multiple sclerosis.
Key WordsPentane lipid peroxidation free radicals multiple sclerosis
Unable to display preview. Download preview PDF.
- 10.Humad S., Zarling E. J., Clapper M., and Skosey J. L. 1988. Breath pentane excretion as a marker of disease activity in rheumatoid arthritis. Free. Rad. Res. Comms. 5:101–106.Google Scholar
- 13.Mickel H. S. 1975. Multiple Sclerosis: A new hypothesis. Perspective in Biology and Medicine. 363–374.Google Scholar
- 20.Sokol R. J. 1988. Vitamin deficiency and neurologic disease. Ann. Rev. Nutr. 8:351–73.Google Scholar
- 22.Srebro Z., Cichoki T., and Godula J. 1971. Peroxidase activity in glia and ependymocytes of the mouse brain. Acta Morphologica. Acad. Sci. Hung. 19:389–395.Google Scholar
- 23.Demopoulos H. B., Flamm E. S., Seligman M. L., Pietronigro D. D., Tomasula J., and DeCrescito V. 1982. Further studies on free-radical pathology in the major central nervous system disorders: effect of very high doses of methylprednisone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury. Can. J. Physiol. Pharmacol. 60:1415–1424.PubMedGoogle Scholar